Skip to main content
UniHealth

Doctor search

Tamiko Robin Katsumoto, MD

Rheumatology · Stanford

NPI 1952571317

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Katsumoto’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A87253 · Current

Licensed to practise in California · since 2004 · expires 2028-03-31 · University of California San Francisco School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$57,065

Medicare paid this office $57,065 for 204 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)89$21,342$158
Long return visit (40+ min)73$12,511$126
Return visit (30+ min)55$6,345$99
New patient visit (60+ min)31$5,043$163
Return visit (30+ min)27$2,295$79
See all 8 services
Every Original Medicare service billed
Long return visit (40+ min)89$21,342$158
Long return visit (40+ min)73$12,511$126
Return visit (30+ min)55$6,345$99
New patient visit (60+ min)31$5,043$163
Return visit (30+ min)27$2,295$79
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's82$1,642$15
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's76$1,513$15
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$583$25

Who their Medicare patients are

204 Original Medicare patients in 2024. Average age 71 · Women 64% · Also on Medicaid 26% · Health risk score 2.28. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 67% · Cancer 38% · Diabetes 29% · Chronic kidney disease 28% · Coronary heart disease 24% · Heart failure 22% · COPD 21% · Atrial fibrillation 21% · Depression 15% · Stroke 7%.

The office billed $229,036, Medicare allowed $74,327 and paid $57,065; for 652 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024204652712.28$229,036$57,065
2023201459712.50$207,771$54,710
2022212502702.30$255,293$56,587
2021219496692.37$287,401$55,597
2020169470682.08$262,595$42,482
2019173330681.98$119,284$35,610
2018100181691.68$81,282$11,583
20131213711.59$7,138$848

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Long return visit (40+ min)117$30,655$126
New patient visit (60+ min)45$7,451$166
Long return visit (40+ min)35$6,112$120
Return visit (30+ min)40$3,753$82
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,315$120
Return visit (30+ min)11$1,155$89

2022: 8 services

Original Medicare services billed in 2022
Long return visit (40+ min)124$30,622$124
Long return visit (40+ min)43$7,747$117
New patient visit (60+ min)25$4,096$164
Return visit (30+ min)44$3,931$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$2,050$93
Return visit (30+ min)17$1,551$82
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,350$123
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or12$404$27

2021: 7 services

Original Medicare services billed in 2021
Long return visit (40+ min)110$25,647$125
New patient visit (60+ min)48$8,102$169
Long return visit (40+ min)48$7,142$123
Return visit (30+ min)51$5,228$87
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$3,723$95
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$1,129$66
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or19$749$30

2020: 8 services

Original Medicare services billed in 2020
Long return visit (40+ min)69$12,320$104
Long return visit (40+ min)65$12,068$113
Return visit (30+ min)61$5,442$69
New patient visit (60+ min)26$3,934$151
Return visit (30+ min)35$3,045$72
New patient visit (60+ min)16$2,913$182
Telehealth originating site facility fee43$1,307$21
Telephone medical discussion with physician, 21-30 minutes12$870$73

2019: 6 services

Original Medicare services billed in 2019
Long return visit (40+ min)58$10,571$107
New patient visit (60+ min)48$7,195$150
Long return visit (40+ min)44$5,571$94
New patient visit (60+ min)24$4,312$180
Return visit (30+ min)33$3,892$93
Return visit (30+ min)27$2,266$69

2018: 5 services

Original Medicare services billed in 2018
Short return visit (20+ min)42$2,608$46
Long return visit (40+ min)16$1,791$105
Aspiration and/or injection of fluid from large joint25$1,640$44
Return visit (30+ min)19$1,625$65
New patient visit (30+ min)17$894$53

Medicaid work

$1,139 in 2023

Medicaid paid $1,139 for 27 billed services this clinician did in 2023, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
Long return visit (40+ min)27$1,139
Medicaid work by year
202327114$1,139
202212112$384
202112112$560
202025212$897
2018225431$188
See the largest Medicaid services in earlier years

2022

Largest Medicaid services in 2022
Long return visit (40+ min)12$384

2021

Largest Medicaid services in 2021
Long return visit (40+ min)12$560

2020

Largest Medicaid services in 2020
Long return visit (40+ min)13$479
Return visit (30+ min)12$418

2018

Largest Medicaid services in 2018
Arthrocentesis and injection of knee joint62$78
New patient visit (30+ min)28$78
Short return visit (20+ min)99$33
Return visit (30+ min)36$0

Drugs they prescribed that Part D paid

$1,311,878

Pharmacies billed $1,311,878 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

664 generic and 160 brand-name prescriptions · $1,311,878 in drug cost · 19 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira(Cf)14$209,623$14,973
Cosentyx Unoready12$89,361$7,447
Taltz13$81,822$6,294
Orencia Clickject11$78,386$7,126
Benlysta12$63,906$5,326
See all 17 drugs
Every Part D drug this clinician prescribed
Humira(Cf)14$209,623$14,973
Cosentyx Unoready12$89,361$7,447
Taltz13$81,822$6,294
Orencia Clickject11$78,386$7,126
Benlysta12$63,906$5,326
Xeljanz Xr11$61,695$5,609
Kevzara12$50,940$4,245
Sildenafil Citrate12$12,459$1,038
Hydroxychloroquine Sulfate129$6,651$52
Mycophenolate Mofetil26$3,875$149
Cevimeline12$3,685$307
Methotrexate110$2,414$22
Prednisone171$2,019$12
Azathioprine11$1,196$109
Colchicine13$295$23
Omeprazole11$269$24
Amlodipine Besylate22$169$8

Year by year

Part D prescribing by year
2024824135None19%$1,311,878
20237011230% (0)17%$963,618
2022989130NoneNone$866,083
2021885128None10%$714,057
2020805110None14%$746,179
2019474106None13%$290,167
2018204857% (14)None$158,810
201524None0% (0)None$9,327
201482None0% (0)18%$13,200
201322224None23%$33,455

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Orencia Clickject28$156,060$5,574
Humira(Cf)15$152,827$10,188
Benlysta19$93,314$4,911
Hydroxychloroquine Sulfate123$8,825$72
Methotrexate95$5,118$54
Pilocarpine13$3,339$257
Mycophenolate Mofetil22$2,925$133
Prednisone118$2,312$20
Leflunomide13$865$67
Omeprazole12$364$30
Amlodipine Besylate19$136$7
Folic Acid14$44$3

2022: 25 drugs

Part D drugs prescribed in 2022
Humira(Cf)13$199,104$15,316
Humira17$146,822$8,637
Benlysta17$102,824$6,048
Cosentyx11$75,923$6,902
Hydroxychloroquine Sulfate190$12,293$65
Methotrexate129$6,751$52
Mycophenolate Mofetil26$6,706$258
Mycophenolic Acid12$4,714$393
Sildenafil Citrate14$4,070$291
Prednisone198$3,537$18
Leflunomide22$2,556$116
Pilocarpine11$2,421$220
Colchicine11$2,206$201
Azathioprine14$579$41
Diclofenac14$467$33
Tadalafil13$460$35
Escitalopram27$348$13
Minocycline11$322$29
Pantoprazole12$269$22
Gabapentin16$228$14
Allopurinol14$201$14
Cilostazol11$145$13
Alendronate11$120$11
Amlodipine Besylate28$118$4
Folic Acid15$95$6

2021: 19 drugs

Part D drugs prescribed in 2021
Humira11$120,052$10,914
Benlysta24$99,386$4,141
Cosentyx Pen (2 Pens)11$70,055$6,369
Hydroxychloroquine Sulfate161$9,903$62
Mycophenolate Mofetil38$4,710$124
Methotrexate94$4,533$48
Sildenafil Citrate13$3,276$252
Prednisone167$3,197$19
Pilocarpine20$2,724$136
Leflunomide25$2,722$109
Gabapentin30$672$22
Diclofenac12$421$35
Pantoprazole15$410$27
Tadalafil12$401$33
Omeprazole16$379$24
Escitalopram20$204$10
Alendronate13$152$12
Amlodipine Besylate29$144$5
Folic Acid11$54$5

2020: 15 drugs

Part D drugs prescribed in 2020
GammaplexImmune globulin13$236,006$18,154
Hydroxychloroquine SulfateNone127$8,785$69
CyclophosphamideNone13$3,727$287
Mycophenolate MofetilNone30$3,320$111
CevimelineNone13$2,974$229
Sildenafil CitrateNone32$2,433$76
PrednisoneNone179$2,356$13
MethotrexateNone58$1,379$24
GabapentinNone43$486$11
TadalafilNone12$401$33
OmeprazoleNone26$393$15
PantoprazoleNone13$288$22
Amlodipine BesylateNone34$143$4
AlendronateNone16$88$5
EscitalopramNone16$56$4

2019: 13 drugs

Part D drugs prescribed in 2019
Xeljanz Xr14$61,516$4,394
Sildenafil Citrate34$16,980$499
Hydroxychloroquine Sulfate46$5,011$109
Mycophenolate Mofetil12$1,485$124
Prednisone96$1,402$15
Methotrexate37$1,099$30
Diclofenac19$687$36
Nifedipine Er11$374$34
Omeprazole19$202$11
Amlodipine Besylate24$168$7
Allopurinol12$158$13
Gabapentin19$135$7
Meloxicam11$42$4

2018: 4 drugs

Part D drugs prescribed in 2018
Enbrel Sureclick12$77,136$6,428
Colcrys13$4,437$341
Hydrocodone-Acetaminophen12$373$31
Prednisone24$258$11

2014: 4 drugs

Part D drugs prescribed in 2014
Methotrexate14$1,125$80
Prednisone20$349$17
Hydroxychloroquine Sulfate18$273$15
Allopurinol13$74$6

2013: 6 drugs

Part D drugs prescribed in 2013
Methotrexate24$1,566$65
Mycophenolate Mofetil14$1,402$100
Hydroxychloroquine Sulfate35$559$16
Prednisone52$546$11
Omeprazole28$512$18
Allopurinol12$76$6

Money from drug and device companies

$63 in 2024

Industry payments by year
202411None$63
202011$1,266$1,266
201944$3,200$3,293

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.None$63
1 payment
  • Meals · 2024-03-07 · $63
See the published payment
Every published payment
E.R. Squibb & Sons L.L.C.Meals · 2024-03-07None$63
See earlier years (2020, 2019)

2020: $1,266

Payments by company in 2020
GenzymeKevzara$1,266
1 payment
  • Consulting for Kevzara · 2020-10-22 · $1,266

2019: $3,293

Payments by company in 2019
AbbVieNone$3,200
1 payment
  • Consulting · 2019-09-29 · $3,200
Boehringer Ingelheim PharmaceuticalsNone$43
1 payment
  • Meals · 2019-01-02 · $43
Janssen Scientific AffairsSimponi Aria$36
1 payment
  • Meals for Simponi Aria · 2019-12-10 · $36
GenzymeRheumatoid Arthritis Disease$15
1 payment
  • Meals for Rheumatoid Arthritis Disease · 2019-10-10 · $15

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Genentech, Inc. · Safety Pk in Patients With Systemic Sclerosis · 2024Their institution$144,832
Genentech, Inc. · Safety Pk in Patients With Systemic Sclerosis · 2025Their institution$73,847
Genentech, Inc. · Safety Pk in Patients With Systemic Sclerosis · 2023Their institution$27,669

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1952571317
Licence
CA A87253California A87253: Current · expires 2028-03-31
Trained
University of California, San Francisco School of Medicine, 2002
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2008-03-01
NPI last updated
2024-04-25
NPI record certified
2024-04-25

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 400 Parnassus Ave, San Francisco, CA, 94143